Changing the paradigm in DME

Developing topical non-invasive therapy for DME, a leading cause of blindness

Nanotechnology for the eye

Our technology enables new topical options for patients with eye diseases

Focused on solving unmet needs in ophthalmology

Our pipeline of topical drug candidates promises improvement
in drug delivery for the back- and front-of-the-eye